Cytokinetics
CEO Robert I. Blum
Country: USA | Funding: $2.4B (+)
Website: https://cytokinetics.com/
Cytokinetics develops first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised.
Website: https://cytokinetics.com/
Cytokinetics develops first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised.
